Tech Company Financing Transactions

Mnemosyne Pharmaceuticals Funding Round

Mnemosyne Pharmaceuticals closed a $5.4 million Series A investment round on 2/17/2012. Investors included Access BridgeGap Ventures and Slater Technology Fund.

Transaction Overview

Announced On
2/17/2012
Transaction Type
Venture Equity
Amount
$5,400,000
Round
Series A
Proceeds Purpose
The company said that it will use the new funds in support of its drug discovery programs, including the identification of lead product candidates for treatment of schizophrenia and other neuropsychiatric disorders.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Technology Sq. 10th Floor
Cambridge, MA 02139
USA
Email Address
Overview
The company is a Providence-based drug discovery venture aiming to develop small molecule therapeutics to treat schizophrenia and other cognitive and neuropsychiatric disorders.
Profile
Mnemosyne Pharmaceuticals LinkedIn Company Profile
Social Media
Mnemosyne Pharmaceuticals Company Twitter Account
Company News
Mnemosyne Pharmaceuticals News
Facebook
Mnemosyne Pharmaceuticals on Facebook
YouTube
Mnemosyne Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Vanessa King
  Vanessa King LinkedIn Profile  Vanessa King Twitter Account  Vanessa King News  Vanessa King on Facebook
Chief Scientific Officer
Tim Piser
  Tim Piser LinkedIn Profile  Tim Piser Twitter Account  Tim Piser News  Tim Piser on Facebook
Vice President
Robert Volkmann
  Robert Volkmann LinkedIn Profile  Robert Volkmann Twitter Account  Robert Volkmann News  Robert Volkmann on Facebook
VP - Operations
David Anderson
  David Anderson LinkedIn Profile  David Anderson Twitter Account  David Anderson News  David Anderson on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/17/2012: Vital Therapies venture capital transaction
Next: 2/17/2012: QuickPay venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary